Genomic Medicine Program Advisory Committee; Notice of Establishment, 14584 [06-2786]

Download as PDF 14584 Federal Register / Vol. 71, No. 55 / Wednesday, March 22, 2006 / Notices cprice-sewell on PROD1PC70 with NOTICES OMB Control Number: 2900–New (28–1903). Type of Review: Existing collection in use without an OMB number. Abstract: VA Form 28–1903 is used to standardize contracts agreements between VA and training facilities/ vendors providing vocational rehabilitation training and employment to veterans. VA uses the data collected to ensure that veterans are receiving the training/employment as agreed in the contract. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. The Federal Register Notice with a 60-day comment period soliciting comments on this collection of information was published on December 9, 2005 at pages 73327– 73328. Affected Public: Business or other forprofit, Not for-profit institutions, Individuals or households, and Farms. Estimated Annual Burden: 1,200 hours. Estimated Average Burden Per Respondent: 60 minutes. Frequency of Response: One-time. Estimated Number of Respondents: 1,200. VerDate Aug<31>2005 14:47 Mar 21, 2006 Jkt 208001 Dated: March 15, 2006. By direction of the Secretary. Denise McLamb, Program Analyst, Records Management Service. [FR Doc. E6–4160 Filed 3–21–06; 8:45 am] BILLING CODE 8320–01–P DEPARTMENT OF VETERANS AFFAIRS Genomic Medicine Program Advisory Committee; Notice of Establishment As required by Section 9(a)(2) of the Federal Advisory Committee Act, the Department of Veterans Affairs hereby gives notice of the establishment of the Department of Veterans Affairs (VA) Genomic Medicine Program Advisory Committee. The Secretary of Veterans Affairs has determined that establishing the Committee is both necessary and in the public interest. The Committee will provide advice to the Secretary of Veterans Affairs on the scientific and ethical issues related to the establishment, development, and operation of a genomic medicine program, and will make recommendations to utilize both genetic and other medical information in PO 00000 Frm 00092 Fmt 4703 Sfmt 4703 concert in order to promote optimal medical care and research that contributes to the Department’s knowledge of diseases and disability. Specifically, the Committee will assess the potential impact of a VA genomic medicine program on existing VA patient care services, make recommendations regarding policies and procedures for tissue collection, storage and analysis, make recommendations on the development of a research agenda and recommend approaches by which research results can be incorporated into routine medical care. Committee members shall be appointed by the Secretary of Veterans Affairs from among knowledgeable experts and veterans with special competence to evaluate the genomic medicine needs of the Department. The Committee shall report regularly to the Secretary of Veterans Affairs on its major activities and recommendations. Dated: March 16, 2006. By Direction of the Secretary. E. Philip Riggin, Committee Management Officer. [FR Doc. 06–2786 Filed 3–21–06; 8:45 am] BILLING CODE 8320–01–M E:\FR\FM\22MRN1.SGM 22MRN1

Agencies

[Federal Register Volume 71, Number 55 (Wednesday, March 22, 2006)]
[Notices]
[Page 14584]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-2786]


-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Genomic Medicine Program Advisory Committee; Notice of 
Establishment

    As required by Section 9(a)(2) of the Federal Advisory Committee 
Act, the Department of Veterans Affairs hereby gives notice of the 
establishment of the Department of Veterans Affairs (VA) Genomic 
Medicine Program Advisory Committee. The Secretary of Veterans Affairs 
has determined that establishing the Committee is both necessary and in 
the public interest.
    The Committee will provide advice to the Secretary of Veterans 
Affairs on the scientific and ethical issues related to the 
establishment, development, and operation of a genomic medicine 
program, and will make recommendations to utilize both genetic and 
other medical information in concert in order to promote optimal 
medical care and research that contributes to the Department's 
knowledge of diseases and disability. Specifically, the Committee will 
assess the potential impact of a VA genomic medicine program on 
existing VA patient care services, make recommendations regarding 
policies and procedures for tissue collection, storage and analysis, 
make recommendations on the development of a research agenda and 
recommend approaches by which research results can be incorporated into 
routine medical care.
    Committee members shall be appointed by the Secretary of Veterans 
Affairs from among knowledgeable experts and veterans with special 
competence to evaluate the genomic medicine needs of the Department. 
The Committee shall report regularly to the Secretary of Veterans 
Affairs on its major activities and recommendations.

    Dated: March 16, 2006.

    By Direction of the Secretary.
E. Philip Riggin,
Committee Management Officer.
[FR Doc. 06-2786 Filed 3-21-06; 8:45 am]
BILLING CODE 8320-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.